Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Non-cash Items (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Non-cash Items for 2 consecutive years, with $6.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 37.5% to $6.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.5 million, a 37.5% decrease, with the full-year FY2024 number at $3.9 million, changed N/A from a year prior.
  • Non-cash Items was $6.5 million for Q3 2025 at Pyxis Oncology, up from $497000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $11.0 million in Q1 2025 to a low of $44000.0 in Q4 2024.